Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein

Cited by (316)

Items 201–300 of 316

  1. AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation
    Lijing Kang, Juanjuan Yi, Chi‐Wai Lau, Lei He, Qinghua Chen, Suowen Xu, Jun Li, Yin Yan Xia, Yuan‐Ting Zhang, Yü Huang et al. · 2023 · Antioxidants
  2. TGF-β/SMAD canonical pathway induces the expression of transcriptional cofactor TAZ in liver cancer cells
    Diana G. Ríos-López, Ángeles C. Tecalco-Cruz, David Martínez-Pastor, Marcela Sosa‐Garrocho, Gustavo Tapia-Urzúa, Yuli Aranda-López, Bibiana Ortega-Domínguez, Félix Recillas Targa, Genaro Vázquez‐Victorio, Marina Macías‐Silva · 2023 · Heliyon
  3. Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer
    Anna Di Benedetto, Marcella Mottolese, Francesca Sperati, Cristiana Ercolani, Luigi Di Lauro, Laura Pizzuti, Patrizia Vici, Irene Terrenato, Abeer M. Shaaban, Matthew P. Humphries et al. · 2016 · Journal of Cellular Physiology
  4. The hippo pathway provides novel insights into lung cancer and mesothelioma treatment
    Xiaolan Liu, Rui Min Zuo, Wen‐Bin Ou · 2018 · Journal of Cancer Research and Clinical Oncology
  5. Metformin and LW6 impairs pancreatic cancer cells and reduces nuclear localization of YAP1
    Xianbin Zhang, Peng Liu, Yuru Shang, Hagen Kerndl, Simone Kumstel, Peng Gong, Brigitte Vollmar, Dietmar Zechner · 2019 · Journal of Cancer
  6. Factors Affecting the Success of Ovum Pick-Up, In Vitro Production and Cryopreservation of Embryos in Cattle
    Farzaneh Salek, Alysha Guest, Chinju Johnson, John Patrick Kastelic, Jacob C. Thundathil · 2025 · Animals
  7. Clinical potential of the Hippo-YAP pathway in bladder cancer
    Xin Cheng, Kecheng Lou, Liang Ding, Xiaofeng Zou, Ruohui Huang, Gang Xu, Junrong Zou, Guoxi Zhang · 2022 · Frontiers in Oncology
  8. Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD/DEN/TAA in a rat model: regulation of AMPK/HIF-1α/YAP-1/TAZ signaling pathways
    Hany M. Fayed, Gihan Farag Asaad, Marawan A. Elbaset, Ola A. Sharaf, Sawsan S. Mahmoud, Mohamed Mahmoud Amin, Zeinab A. El‐Gendy, Fatma A. Ibrahim, Sherein Saied. Abdelgayed, Rehab Fawzy Abdel-Rahman · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  9. Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
    Seong Hwi Hong, Hyun Ji Hwang, Da Hyeon Son, Eun Song Kim, Sung Yul Park, Young Eun Yoon · 2023 · FEBS Open Bio
  10. The LINC Complex Assists the Nuclear Import of Mechanosensitive Transcriptional Regulators
    Tomoyo Takata, Miki Matsumura · 2022 · Results and problems in cell differentiation
  11. The hippo pathway: a molecular bridge between environmental cues and pace of life
    Ehsan Pashay Ahi, Bineet Panda, Craig Robert Primmer · 2025 · BMC Ecology and Evolution
  12. Energy stress tames the Hippo pathway
    Iswar K. Hariharan · 2015 · Nature Cell Biology
  13. Devo-Aging: Intersections Between Development and Aging
    Carlos G. Silva-García · 2023 · GeroScience
  14. 4-Acetylantrocamol LT3, a New Ubiquinone from Antrodia cinnamomea, Inhibits Hepatocellular Carcinoma HepG2 Cell Growth by Targeting YAP/TAZ, mTOR, and WNT/β-Catenin Signaling
    Yen‐Lin Chen, I‐Chuan Yen, Kuen‐Tze Lin, Feng-Yi Lai, Shih‐Yu Lee · 2020 · The American Journal of Chinese Medicine
  15. New insights in Hippo signalling alteration in human papillomavirus-related cancers
    Leslie Olmedo‐Nieva, J. Omar Muñoz-Bello, Joaquín Manzo-Merino, Marcela Lizano · 2020 · Cellular Signalling
  16. D-ribose-5-phosphate inactivates YAP and functions as a metabolic checkpoint
    Chenge Tu, Yongfeng Liu, Hong-Wei Liu, Chun-Mei Jiao, Quentin Liu, Mien‐Chie Hung, Peng Li, Xiang Wan, Xin-Juan Fan, Yunlong Wang · 2025 · Journal of Hematology & Oncology
  17. HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma
    Sathya Neelature Sriramareddy, Fernanda Faião‐Flores, Michael F. Emmons, Biswarup Saha, Srikumar Chellappan, Clayton J. Wyatt, Inna Smalley, Jonathan D. Licht, Michael A. Durante, J. William Harbour et al. · 2022 · Cancer Gene Therapy
  18. Potential Role of Exercise in Regulating YAP and TAZ During Cardiomyocytes Aging
    Yenni Limyati, Ardo Sanjaya, Teresa Lucretia, Julia Windi Gunadi, Vitriana Biben, Diana Krisanti Jasaputra, Ronny Lesmana · 2022 · Current Cardiology Reviews
  19. Licochalcone A inhibits cell growth through the downregulation of the Hippo pathway via PES1 in cholangiocarcinoma cells
    Kedong Xu, Yi Miao, Pan Li, Pingping Li, Jie Liu, Juan Li, Fang Cao · 2021 · Environmental Toxicology
  20. The NDR family of kinases: essential regulators of aging
    Kevin Jonischkies, Miguel del Ángel, Yunus Emre Demiray, Allison Loaiza Zambrano, Oliver Stork · 2024 · Frontiers in Molecular Neuroscience
  21. Engineering stem cell metabolism using biomaterial-induced mechanotransduction
    Juul Verbakel, Jan de Boer · 2025 · Cell Biomaterials
  22. Photobiomodulation therapy activates YAP and triggers proliferation and dedifferentiation of Müller glia in mammalian retina
    Seoyeon Kim, Myung-Jun Song, In‐Beom Kim, Tae Kwan Park, Jungmook Lyu · 2023 · BMB Reports
  23. Hippo pathway cooperates with ChREBP to regulate hepatic glucose utilization
    Zhiping Shu, Guiwen Yi, Shan Deng, Kai Huang, Yan Wang · 2020 · Biochemical and Biophysical Research Communications
  24. O-GlcNAcylation: An Emerging Protein Modification Regulating the Hippo Pathway
    Eunah Kim, Jeong Gu Kang, Eek‐hoon Jho, Won Ho Yang, Jin Won Cho · 2022 · Cancers
  25. Energy restriction affect liver development in Hu sheep ram lambs through Hippo signaling pathway
    Ting-Ting Zhang, Guomin Zhang, Yuhang Jin, Yixuan Guo, Zhen Wang, Yixuan Fan, M.A. El-Samahy, Feng Wang · 2017 · Tissue and Cell
  26. Roles of Yes-associated protein and transcriptional coactivator with PDZ-binding motif in non-neoplastic liver diseases
    Di Chen, Hongmei Zhang, Xin Zhang, Xia Sun, Qiaohong Qin, Ying Hou, Min Jia, Yulong Chen · 2022 · Biomedicine & Pharmacotherapy
  27. Clinical Potential of Misshapen/NIKs-Related Kinase (MINK) 1—A Many-Sided Element of Cell Physiology and Pathology
    Anna Kot, Dominika Koszewska, Błażej Ochman, Elżbieta Świętochowska · 2024 · Current Issues in Molecular Biology
  28. Angiomotin‐like 1 plays a tumor‐promoting role in glioma by enhancing the activation of YAP1 signaling
    Gang Xu, Zhi-yuan Seng, Ming Zhang, Jianqiang Qu · 2021 · Environmental Toxicology
  29. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers
    Yifei Wang, Huarong Chen, Jun Qing Yu, Wei Kang, Ka Fai To · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  30. Integrating Genetic Alterations and the Hippo Pathway in Head and Neck Squamous Cell Carcinoma for Future Precision Medicine
    Toshinori Ando, Kento Okamoto, Tomoaki Shintani, Souichi Yanamoto, Mutsumi Miyauchi, Jorge Silvio Gutkind, Mikihito Kajiya · 2022 · Journal of Personalized Medicine
  31. Insulin suppresses transcriptional activity of yes-associated protein in insulin target cells
    Samar Sayedyahossein, Andrew C. Hedman, David B. Sacks · 2019 · Molecular Biology of the Cell
  32. Regulation of myocardial glucose metabolism by YAP/TAZ signaling
    Toshihide Kashihara, Junichi Sadoshima · 2024 · Journal of Cardiology
  33. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy
    Jun Zhu, Tiantian Wu, Qiong Lin · 2023 · Molecular Biology Reports
  34. Urolithin A exerts anti-tumor effects on gastric cancer via activating autophagy-Hippo axis and modulating the gut microbiota
    Yixiao Qiao, Qiaoyun Xia, Xukun Cao, Jing‐Yuan Xu, Zhengdong Qiao, Longyun Wu, Zhirong Chen, Longbao Yang, Xiaolan Lu · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  35. Reduced angiomotin p130 expression correlates with poor prognosis in lung adenocarcinoma
    Si‐Hyong Jang, Hyun Deuk Cho, Ji‐Hye Lee, Hyun Ju Lee, Soon Auck Hong, Junhun Cho, Han Jo Kim, Mee‐Hye Oh · 2016 · Journal of Clinical Pathology
  36. The Regulation and Function of Hippo/ YAP Pathway in Cancer
    Chinmoy Ghosh, Ruchi Kakar, Seline Torkamboor, Yue Sun · 2026 · The FASEB Journal
  37. Focusing on Hippo Pathway in Stem Cells of Oral Origin, Enamel Formation and Periodontium Regeneration
    Tianyi Wang, Kehan Li, Hanghang Liu, En Luo · 2022 · Organogenesis
  38. Low PRKAB2 Expression Is Associated with Poor Outcomes in Pediatric Adrenocortical Tumors, and Treatment with Rottlerin Increases the PRKAB2 Level and Inhibits Tumorigenic Aspects in the NCI-H295R Adrenocortical Cancer Cell Line
    Alcides Euzebio Tavares Xavier, Luciana Chain Veronez, Luís Fernando Peinado Nagano, Carolina Alves Pereira Corrêa, Mirella Baroni, Milena Silva Ramos, Rosane Queiroz, Carlos Augusto Fernandes Molina, José Andrés Yunes, Sílvia Regina Brandalise et al. · 2024 · Cancers
  39. Proteomic analysis reveals oxidative stress-induced activation of Hippo signaling in thiamethoxam-exposed Drosophila
    Xiaoqin Li, Mingquan Li, Xianle Xue, Xing Wang · 2023 · Chemosphere
  40. Glycolysis-related lncRNA FTX upregulates YAP1 to facilitate colorectal cancer progression via sponging miR-215-3p
    Jinlan Yang, Jingjing Ma, Tianyin Qu, Qing Dai, Jing Leng, Lin Fang, Jie Wu, Yajun Li, Huangfei Yu · 2025 · Scientific Reports
  41. Reciprocal Regulation of Hippo and WBP2 Signalling—Implications in Cancer Therapy
    Yvonne Xinyi Lim, Yvonne Xinyi Lim, Sock Hong Seah, Yoon Pin Lim · 2021 · Cells
  42. The molecular crosstalk of the hippo cascade in breast cancer: A potential central susceptibility
    Sulfath Thottungal Parambil, Gisha Rose Antony, Ajeesh Babu Littleflower, Lakshmi Subhadradevi · 2024 · Biochimie
  43. Involvement of Tight Junction Plaque Proteins in Cancer
    Lorenza González‐Mariscal, Jael Miranda, José Mario Ortega-Olvera, Helios Gallego-Gutiérrez, Arturo Raya‐Sandino, Orlando Vargas-Sierra · 2016 · Current Pathobiology Reports
  44. Targeting the Hippo Pathway to Improve Response to Chemotherapy
    Yulei Zhao, Xiaolong Yang · 2018 · Elsevier eBooks
  45. Proteasome stress activates YAP/TAZ through the RAP2–MAP4Ks–LATS1/2 pathway and its therapeutic implications in solid tumors
    Xin Wang, Yuan Gu, Zhenxing Zhong, Pengcheng Yu, Wenshuai Liu, Rui Zhu, Yu Wang, Zhaocai Zhou, Yihong Sun, Xuefei Wang et al. · 2025 · Proceedings of the National Academy of Sciences
  46. Activation of Yap-Directed Transcription by Knockdown of Conserved Cellular Functions
    Claudia Agarinis, Vanessa Orsini, Philippe Megel, Yann Abraham, Haidi Yang, Craig Mickanin, Vic E. Myer, Tewis Bouwmeester, Jan S. Tchorz, Christian N. Parker · 2015 · SLAS DISCOVERY
  47. Role of angiomotin family members in human diseases (Review)
    Haoyun Wang, Ye Meng, Xiaofeng Jin · 2024 · Experimental and Therapeutic Medicine
  48. Interplay of Glucose Metabolism and Hippo Pathway in Chondrocytes: Pathophysiology and Therapeutic Targets
    Jacob Jahn, Quinn T. Ehlen, Lee D. Kaplan, Thomas Michael Best, Zhipeng Meng, Chun-Yuh Charles Huang · 2024 · Bioengineering
  49. Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells
    Takashi Yokouchi, Tsuyoshi Takahashi, Toshirou Nishida, Koji Tanaka, Yukinori Kurokawa, Kazuyoshi Yamamoto, Takuro Saito, Takaomi Hagi, Kota Momose, Kotaro Yamashita et al. · 2025 · Gastric Cancer
  50. The TRPV4-YAP axis mediates cytoskeletal and extracellular matrix remodeling in trabecular meshwork cells as a novel glaucoma mechanism
    Jing Xu, Kexin Liu, Feng Wang, Ying Su · 2025 · Scientific Reports
  51. YAP upregulates AMPKα1 to induce cancer cell senescence
    Yongtong Zhan, Guihao Wu, Xuhong Fan, Ze Fu, Yue Ni, Beini Sun, Hongce Chen, Tongsheng Chen, Xiaoping Wang · 2024 · The International Journal of Biochemistry & Cell Biology
  52. Energy crisis and the Hippo pathway
    Wenqi Wang, Xu Li, Junjie Chen · 2015 · Cell Cycle
  53. Molecular insights of Hippo signaling in the chick developing lung
    Violina Baranauskaite Barbosa, Pedro F. Costa-Silva, Henrique Araújo-Silva, Gonçalo Miranda, Jorge Correia‐Pinto, Rute Silva Moura · 2022 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  54. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
    Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Zhiyong Xiong, Hongmei Yang, Xiaoping Zhang · 2023 · BMC Cancer
  55. Studying the Geroprotective Properties of YAP/TAZ Signaling Inhibitors on Drosophila melanogaster Model
    Denis Golubev, Nadezhda Vladimirovna Zemskaya, Anastasia A. Gorbunova, Daria V. Kukuman, Alexey Moskalev, Mikhail Vyacheslavovich Shaposhnikov · 2023 · International Journal of Molecular Sciences
  56. Identification of BRCC3 and BRCA1 as Regulators of TAZ Stability and Activity
    Silvia Sberna, Alejandro Lopez-Hernandez, Chiara Biancotto, Luca Motta, Adrian Andronache, Lisette G. G. C. Verhoef, Marieta Cagánová, Stefano Campaner · 2023 · Cells
  57. Deciphering Potential Role of Hippo Signaling Pathway in Breast Cancer: A Comprehensive Review
    Hunayna M. Bhavnagari, Apexa P. Raval, Franky Dhaval Shah · 2023 · Current Pharmaceutical Design
  58. TGF-β and HIPPO Signaling Pathways Interplay in Distinct Hepatic Contexts
    Víctor Manuel Color-Aparicio, Ángeles C. Tecalco-Cruz, Blanca Delgado‐Coello, Marcela Sosa‐Garrocho, Jaime Mas‐Oliva, Genaro Vázquez‐Victorio, Marina Macías‐Silva · 2024 · Gene Expression
  59. Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure–activity relationship
    E Haripriya, K. Hemalatha, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, Pronoy Kanti Das, M. D. Ashadul Sk, S. Mounika, M. P. Viji, I. Aayishamma, K. R. Jayashree · 2024 · Molecular Diversity
  60. MST3 Regulates AMPK and YAP-Hippo Signaling in Cell Models Relevant to Renal Fibrosis
    Chee-Hong Chan, Te‐Jung Lu, Bo‐Ying Bao, Po-Chen Chu, Yu-Kai Chen, Syuan-Long Syu, W.Y. Jeng, Te‐Ling Lu · 2025 · Biomolecules & Therapeutics
  61. Metformin‐Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention
    Ambulugala Gamage Rajika Greshamali Jinadasa, N. D. A. Wageesha, Sameera R. Samarakoon, S. Ekanayake, H.M.K. Akalanka · 2026 · Cancer Medicine
  62. Promotion of breast cancer by the DNPH1 enzyme
    Sangphil Oh, Yuan Sui, Sook Shin, Ralf Janknecht · 2026 · iScience
  63. FATP5 modulates biological activity and lipid metabolism in prostate cancer through the TEAD4-mediated Hippo signaling
    Shenyang Liu, Yi He, Zhengqin Gu · 2024 · Frontiers in Oncology
  64. The Role of Hippo Signaling in Intestinal Homeostasis
    Xiaoya Ma, Yatrik Madhukar Shah · 2018 · Elsevier eBooks
  65. Integrative High-Throughput RNAi Screening Identifies BRSK1, STK32C and STK40 as Novel Activators of YAP/TAZ
    Mandeep K. Gill, Siyuan Song, Tania Y. Christova, Liliana Attisano · 2025 · International Journal of Molecular Sciences
  66. AMPK Signaling Regulates Epithelioid Hemangioendothelioma Cell Growth
    Ryan Kanai, Sarah McMullan, Pukar Baniya, Roselyn S. Dai, Emily Norton, Kaila Lasher, Chloe T Purello, Caleb Nathaniel Seavey, Brian P. Rubin, John M. Lamar · 2025 · Cancers
  67. Irg1l regulates neuromast size via metabolic reprogramming to promote supporting cell proliferation
    Xin Wang, Ruijun Shi, Yuqing Xiang, Yajing Gao, Guoqiang Wan, Shan Sun, Dong Liu · 2025 · The Journal of Cell Biology
  68. Phosphatase PPP1CC Regulates the First Lineage Segregation by GAS5 in Mouse Preimplantation Embryos
    Jianwu Wang, Yan Zhang, Laijin Wu, Hongshuang Xie, Guang Yang, Yiwei Zhang, Cheng Huang, Shanyi Chou, Xuehan Li, Z.H. Liu et al. · 2025 · Cell Proliferation
  69. Hippo signalling in cellular and tissue-level metabolism across health and disease
    Sophia Bigot, Aida Bahrami, Amin Dakhili Ardestani · 2026 · Trends in Endocrinology and Metabolism
  70. The Hippo-YAP/TAZ axis: A central signaling hub integrating diverse cues to regulate cellular senescence
    Shiqing Tan, Xueqin Huang, Junyao Li, Eugenie Nepovimová, Marián Valko, Qinghua Wu, Kamil Kuča · 2026 · Mechanisms of Ageing and Development
  71. Emerging Roles of YAP/TAZ in Mechanobiology
    Yubing Sun, Yue Shao, Xufeng Xue, Jianping Fu · 2016 · Springer eBooks
  72. Hippo signaling pathway regulation of innate immune response
    ChengGang ZOU, Hui Han, YiCheng MA · 2019 · Scientia Sinica Vitae
  73. Clinical report: Chronic liver dysfunction in an individual with an AMOTL1 variant
    Shizuka Kirino, Mitsuyoshi Suzuki, Takuya Ogawa, Kei Takasawa, Eriko Adachi, Maki Gau, Ken Takahashi, Mitsuru Ikeno, Mamiko Yamada, Hisato Suzuki et al. · 2022 · European Journal of Medical Genetics
  74. The cellular localization and oncogenic or tumor suppressive effects of angiomiotin‐like protein 2 in tumor and normal cells
    Huizhen Wang, Jing Li, Kexun Yu, Yida Lu, Mengdi Ma, Yongxiang Li · 2024 · IUBMB Life
  75. Intraflagellar transport complex B proteins regulate the Hippo effector Yap1 during cardiogenesis
    Marina Peralta, Kateřina Jeřábková, Tommaso Lucchesi, Laia Ortiz López, Benjamin Vitre, Dong Han, Laurent Guillemot, Chaitanya Dingare, Izabela Sumara, Nadia Mercader et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Transcriptional reprogramming in fused cells is triggered by plasma-membrane diminution
    Daniel Feliciano, Isabel Espinosa-Medina, Aubrey V. Weigel, Kristin M. Milano, Zhonghua Tang, Tzumin Lee, Harvey J. Kliman, Seth M. Guller, Carolyn M. Ott, Jennifer Lippincott‐Schwartz · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  77. The role of POPX2 in the regulation of hippo pathway
    Bakhait Rahmat Muhammad · 2018
  78. Identification and Characterization of Novel Upstream Regulators of the Hippo Signalling Pathway
    Emad Heidaryarash · 2018 · TSpace (University of Toronto)
  79. Hippo pathway control of KSHV latency
    Siobhan O’Brien · 2018
  80. Metabolic Reprogramming Promotes Metastasis of Acidosis-Adapted Pancreatic Ductal Adenocarcinoma Cells Via AMPK/YAP/MMP1 Axis
    Siyuan Chen, Bo Ning, Jin‐Wen Song, Zihan Yang, Li Zhou, Zhiji Chen, Lin‐Hong Mao, Hongtao Liu, Qingliang Wang, Song He et al. · 2021 · Research Square
  81. Molecular Heterogeneity in Primary and Metastatic Prostate Tumor Tissue
    Julie L. Batista · 2015 · Defense Technical Information Center (DTIC)
  82. Effect of CLN3-loss-of-function on cellular metabolism and signalling
    Katarzyna Więciorek-Płuciennik · 2022
  83. Hepatic Yap1 activates systemic catabolism and muscle loss during organ repair: evidence for a liver-derived common mechanism with cancer cachexia
    Tewfik Hamidi, Yanlin Jiang, Tyler P. Robinson, Andris Kronbergs, Ernie D. Au, Joseph E. Rupert, Xiaoling Zhong, Siangsin Lal, Tiffany W. Liang, Alexander G. Robling et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  84. Nuclear and cytoplasmic remodeling of ectocervical cells by high activity of gelsolin
    Bálint Farkas, Zoltán Szatmári, Krisztina Kovács, Kálmán András Kovács, Nikoletta Bárdos, Katalin Türmer, Orsolya Mária Kovács, Lívia Czimbalek, Dávid Szatmári · 2025 · Scientific Reports
  85. The ARK side of the cell: Kinases, metabolism, and therapeutic potential in malignancies
    Viviana Coliboro-Dannich, Alejandro Farías, Luis Espinoza-Francine, M Andrea Concha-Vega, Karen Almendras-Durán, Ana María Salazar, Roxana Pincheira, Ariel Fernando Castro · 2025 · Pharmacological Research
  86. Additional file 3 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
    Diaoyi Tan, Daojia Miao, Zhao, Chuanyi, Shi, Jian, Qingyang Lv, Zhiyong Xiong, Hongmei Yang, Zhang, Xiaoping · 2023 · Figshare
  87. Additional file 5 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
    Diaoyi Tan, Daojia Miao, Zhao, Chuanyi, Shi, Jian, Qingyang Lv, Zhiyong Xiong, Hongmei Yang, Xiaoping Zhang · 2023 · Figshare
  88. Additional file 2 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
    Diaoyi Tan, Daojia Miao, Zhao, Chuanyi, Shi, Jian, Qingyang Lv, Zhiyong Xiong, Hongmei Yang, Zhang, Xiaoping · 2023 · Figshare
  89. Additional file 1 of Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
    Federica Iannelli, Maria Serena Roca, Rita Lombardi, Chiara Ciardiello, Laura Grumetti, Simona De Rienzo, Tania Moccia, Carlo Vitagliano, Angela Sorice, Costantini, Susan et al. · 2020 · Figshare
  90. Additional file 4 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
    Diaoyi Tan, Daojia Miao, Zhao, Chuanyi, Shi, Jian, Qingyang Lv, Zhiyong Xiong, Hongmei Yang, Xiaoping Zhang · 2023 · Figshare
  91. Additional file 1 of Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
    Diaoyi Tan, Daojia Miao, Zhao, Chuanyi, Shi, Jian, Qingyang Lv, Zhiyong Xiong, Hongmei Yang, Xiaoping Zhang · 2023 · Figshare
  92. Additional file 2 of Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
    Federica Iannelli, Maria Serena Roca, Rita Lombardi, Chiara Ciardiello, Laura Grumetti, Simona De Rienzo, Tania Moccia, Carlo Vitagliano, Angela Sorice, Costantini, Susan et al. · 2020 · Figshare
  93. Exploring Mesenchymal Stromal Cells as a Potential Therapy for Comorbid Osteoarthritis and Type 2 Diabetes Mellitus
    Meiling Liu, Siyi Xie, Yajie Kong, Yiming Yang, Ruixue Chen, Yuzhong Wang, Shuxing Cao, Yongzhou Song · 2025 · Stem Cells International
  94. YAP1 Is a Crucial Nexus in the Tumor Microenvironment
    Raghavan Narasimhan, Anshula Narayanasamy, Jaya Padmanabhan, Srikumar Chellappan, Durairaj Mohan Kumar · 2026 · Current Medical Science
  95. α-Ketoglutarate couples cellular metabolism to developmental growth via hydroxylation-dependent degradation of Yorkie
    Tao He, Yongchang Zeng, Jie Zhou, Yuqi Tian, Donggui Wang, Jingchao Ma, Jiyong Liu, Wenqi Wu, Chuanxian Wei, Renjie Jiao · 2026 · Cell Reports
  96. Brain cancer: Hippo signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
    Mehrose Ayoub Bhat, Insha Mushtaq, Weekar Younus Raja · 2026 · Elsevier eBooks
  97. TAZ WW Domain-Mediated Regulation of Gluconeogenesis and Tumorigenesis in Hepatocellular Carcinoma through Interaction with the Glucocorticoid Receptor
    Hongxiang Huang, Jinhong Chen, Xingyu Tao, Peiyuan Zhong, Yanqiu Meng, SuJuan Peng, Wanying Luo, Zhiyong He, Shuai Luo, Xie Zhu et al. · 2026 · Endocrinology and Metabolism
  98. Étude du dialogue entre la voie Wnt/β-caténine et LKB1 dans la physiopathologie hépatique
    Sara Charawi · 2017 · theses.fr (ABES)
  99. Place de la signalisation Hippo dans l'histoire naturelle du Mésothéliome Pleural Malin (MPM) : dissection de ses rôles dans les lignées mésothéliales pleurales humaines et application à la caractérisation moléculaire des 448 patients atteints de MPM inclus dans l'essai clinique de phase 3 "MAPS"
    Elodie Maille · 2018
  100. Rôle de la voie de signalisation Hippo dans le développement des ostéosarcomes
    Sarah Morice · 2019 · theses.fr (ABES)